Thoracic 131I Uptake After Previous Pneumonectomy in Patients Treated for Differentiated Thyroid Cancer

被引:5
|
作者
Nascimento, Camila [1 ]
Bridji, Boumediene [2 ]
Dejax, Catherine [3 ]
Schlumberger, Martin [1 ]
Leboulleux, Sophie [1 ]
机构
[1] Inst Gustave Roussy, Dept Nucl Med & Endocrine Oncol, F-94805 Villejuif, France
[2] Ctr Rene Gauducheau, Dept Nucl Med, St Herblain, France
[3] Ctr Jean Perrin, Dept Nucl Med, Clermont Ferrand, France
关键词
differentiated thyroid cancer; pneumonectomy; I-131; whole-body scan; thoracic uptake; PERICARDIAL-EFFUSION; SCINTIGRAPHY; CARCINOMA; SCAN;
D O I
10.1097/RLU.0b013e3182485146
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
In patients treated for differentiated thyroid cancer with radioiodine (I), abnormal uptake on post-therapeutic whole-body scan may lead to repeated administration of I. Uptake not linked to thyroid cancer but to other conditions should be recognized so that patients are not overtreated. We describe 3 cases of unilateral thoracic I uptake in patients previously treated by pneumonectomy for lung cancer, without evidence of persistent lung cancer. © 2012 by Lippincott Williams & Wilkins.
引用
收藏
页码:587 / 590
页数:4
相关论文
共 50 条
  • [1] UPTAKE OF 131I IN HOUSEHOLDS OF THYROID CANCER PATIENTS
    North, David L.
    [J]. HEALTH PHYSICS, 2013, 104 (04): : 434 - 436
  • [2] Dosimetry clinical application in differentiated thyroid cancer treated with 131I
    Testanera, G.
    Antunovic, L.
    Tosi, G.
    Pusceddu, M.
    Leonardi, L.
    Roffinengo, C.
    Tarullo, G.
    Chiti, A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S463 - S463
  • [3] Interrupted 131I Procedures for Patients With Differentiated Thyroid Cancer
    Karls, Shawn
    Abikhzer, Gad
    Tamilia, Michael
    Probst, Stephan
    [J]. CLINICAL NUCLEAR MEDICINE, 2017, 42 (04) : 247 - 249
  • [4] Radiation dose rates of differentiated thyroid cancer patients after 131I therapy
    Jin, Pingyan
    Feng, Huijuan
    Ouyang, Wei
    Wu, Juqing
    Chen, Pan
    Wang, Jing
    Sun, Yungang
    Xian, Jialang
    Huang, Liuhua
    [J]. RADIATION AND ENVIRONMENTAL BIOPHYSICS, 2018, 57 (02) : 169 - 177
  • [5] Radiation dose rates of differentiated thyroid cancer patients after 131I therapy
    Pingyan Jin
    Huijuan Feng
    Wei Ouyang
    Juqing Wu
    Pan Chen
    Jing Wang
    Yungang Sun
    Jialang Xian
    Liuhua Huang
    [J]. Radiation and Environmental Biophysics, 2018, 57 : 169 - 177
  • [6] 131I thyroid uptake in patients treated with 131I-Lipiodol for hepatocellular carcinoma
    Toubeau, M
    Touzery, C
    Berriolo-Riedinger, A
    Cochet, A
    Brunotte, F
    Bedenne, L
    Cercueil, JP
    Krause, D
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (05) : 669 - 670
  • [7] 131I thyroid uptake in patients treated with 131I-Lipiodol for hepatocellular carcinoma
    Michel Toubeau
    Claude Touzery
    Alina Berriolo-Riedinger
    Alexandre Cochet
    François Brunotte
    Laurent Bedenne
    Jean-Pierre Cercueil
    Denis Krause
    [J]. European Journal of Nuclear Medicine, 2001, 28 : 669 - 670
  • [8] Thyroid uptake of liquid versus capsule 131I tracers in hyperthyroid patients treated with liquid 131I
    Rini, JN
    Vallabhajosula, S
    Zanzonico, P
    Hurley, JR
    Becker, DV
    Goldsmith, SJ
    [J]. THYROID, 1999, 9 (04) : 347 - 352
  • [9] 131I imaging in the therapy of differentiated thyroid cancer
    Vija, L. -M.
    Toubert, M. -E.
    [J]. MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2012, 36 (01): : 44 - 51
  • [10] Value of thyroglobulin to 131I uptake ratio in selection of initial therapy dose of 131I in patients with differentiated thyroid carcinoma
    Gerali, S
    Koutsikos, J
    Tsiouris, S
    Mainta, E
    Lucchetti, S
    Papathanasiou, G
    Fotinaki, E
    Makripoulias, V
    Kotsias, D
    Palestidis, C
    Zerva, C
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S425 - S425